Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2008

Jun 10, 2008

65122_rns_2008-06-10_ac8c86e0-b9bb-4596-82f2-03f2a520da38.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
90 009 237 889
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: MR. ATA GOKYILDIRIM
Date of Last Notice: 20thDecember 2007

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest Indirect Indirect
Nature of Indirect Interest(including registered holder) Note:Provide details of the circumstances giving rise to the relevantinterest. Director Related Entity
Date of change (a) 5thJune 2008(b) 6th June 2008
No. of securities held prior to change Options---
Shares Options
Direct - -
Indirect - -
Total - -
Class Listed Options (PRRO)
Number Acquired Options-18,000,00018,000,000
Shares Options
Direct - -
Indirect - 18,000,000
Total - 18,000,000
Number Disposed Nil
Value/ConsiderationNote:If consideration is non-cash, provide details and estimated valuation (a) 10,000,000 options (see below) – Nil(b) 8,000,000 options (see below) -$0.002per option
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of Securities Held After Change SharesOptionsDirect--Indirect-18,000,000Total-18,000,000 SharesOptionsDirect--Indirect-18,000,000Total-18,000,000 SharesOptionsDirect--Indirect-18,000,000Total-18,000,000
Shares Options
Direct - -
Indirect - 18,000,000
Total - 18,000,000
Nature of ChangeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back (a)10,000,000 PRRO options issued perResolution 1 approved at GeneralMeeting dated 4thJune 2008.(b)8,000,000 PRRO options acquired byoff-market transfer

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder(if issued securities)
Date of Change
No. and Class of Securities toWhich Interest Related Prior toChangeNote:Details are only required for a contract in relation towhich the interest has changed
Interest Acquired
Interest Disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest After Change

==> picture [24 x 15] intentionally omitted <==

www.thecfo.com.au 11.06.2008

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX: PRR)
ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: MR. MARTIN ROGERS
Date of Last Notice: 16 October 2007

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest Indirect Indirect
Nature of Indirect Interest Director related entity
(including registered holder)
Note:Provide details of the circumstances giving rise to the relevant
interest.
Date of change (a) 5thJune 2008
(b) 6th June 2008
No. of securities held prior to change Shares Options
Direct - -
Indirect - -
Total - -
Class Listed Options (PRRO)
Number Acquired Shares Options
Direct - -
Indirect - 18,000,000
Total - 18,000,000
Number Disposed Nil
Value/Consideration (a) 10,000,000 options (see below) – Nil
Note:If consideration is non-cash, provide details and estimated valuation (c) 8,000,000 options (see below) -
$0.002 per option
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of Securities Held After Change Options-18,000,00018,000,000
Shares Options
Direct - -
Indirect - 18,000,000
Total - 18,000,000
Nature of ChangeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back (a)10,000,000 PRRO options issued perResolution 3 approved at GeneralMeeting dated 4thJune 2008.(b)8,000,000 PRRO options acquired byoff-market transfer.

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder(if issued securities)
Date of Change
No. and Class of Securities toWhich Interest Related Prior toChangeNote:Details are only required for a contract in relation towhich the interest has changed
Interest Acquired
Interest Disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest After Change

==> picture [24 x 15] intentionally omitted <==

www.thecfo.com.au

11.06.2008

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
90 009 237 889
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: DR. RICHARD HAMMEL
Date of Last Notice: 23rdNovember 2005

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest (a) Direct (Unlisted Options)(b) Indirect (Listed Options PRRO) (a) Direct (Unlisted Options)(b) Indirect (Listed Options PRRO) (a) Direct (Unlisted Options)(b) Indirect (Listed Options PRRO)
Nature of Indirect Interest(including registered holder) Note:Provide details of the circumstances giving rise to the relevantinterest. (b) Director related entity
Date of change (b) 6thJune 2008
No. of securities held prior to change Options 500,000-500,000
Shares Options
Direct - 500,000
Indirect - -
Total - 500,000
Class Listed Options (PRRO)
Number Acquired Options-10,000,00010,000,000
Shares Options
Direct - -
Indirect - 10,000,000
Total - 10,000,000
Number Disposed Nil
Value/ConsiderationNote:If consideration is non-cash, provide details and estimated valuation Nil
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y Appendix 3Y Appendix 3Y
Change of Director’s Interest Notice
SharesOptions
No. of Securities Held After Change Options
Shares Options
Direct - 500,000
Indirect - 10000000
,,
T otal -
Nature of ChangeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back 10,000,000PRROoptionsissuedperResolution 2 approved at General Meetingdated 4thJune 2008.

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of ContractNature of InterestName of Registered Holder
(if issuDate oNo. anWhichChan ed securities)
f Change
d Class of SecuInterest Relatge ritieed P s torior to
Note:DetaiwhicIntereIntereValueNote: If cestimatedIntere ls are only required for ah the interest has changed contrac t in relatio n to
st Acquired
st Disposed
/Considerationonsideration is non-cash,valuation provide details an d an
st After Chang e

==> picture [24 x 15] intentionally omitted <==

www.thecfo.com.au

11.06.2008

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002